Thomas Marron

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Astellas
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Regeneron
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Regeneron
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    BMS
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Boehringer Ingelheim
    Date added:
    06/04/2024
    Date updated:
    06/04/2024

Pages

Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology